CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas
Clinical trial NCT03387592 · TERMINATED
Trial details
- NCT number
- NCT03387592
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-06
- Primary completion
- 2022-02-28
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.